Introduction:
Diabetes is the common cause of mortality & morbidity in all over the World. The global prevalence of Type 2 diabetes will be double between 1995 & 2025, to 270 million people with the greatest number of cases being expected in China & India
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.Type 2 diabetes is the common form of diabetes accounting for 85% -95 % of all cases of diabetes worldwide, and affecting 5% -7% of the World's population. Increased prevalence of type 2 diabetic patients has been reported among overweight & obese persons as a consequence of unhealthy lifestyle 2 . the prevalence of Type 2 diabetes in India is up to 20% in adult population in some urban areas. The commonest cause of mortality & morbidity in Type 2 diabetes is cerebrovascular accident & coronary artery disease. The study shows that only good blood glucose control, along with BP control in Type 2 diabetic patients cannot reduce mortality & morbidity due to cerebrovascular accident & coronary artery disease; but dyslipidaemia& life style modification is the cornerstone to reduce mortality & morbidity for those events. Dyslipidaemia in diabetes mellitus is a common accompaniment. Diabetic dyslipidemia is increased VLDL / serum triglycerides decreased HDL average levels of LDL but with a predominance of small, dense LDL Diabetic dyslipidemia is due, largely, to insulin resistance, insulin resistance increases hepatic secretion of VLDL → preferential formation of small, dense LDL increases HDL catabolism (cholesterol ester transfer protein dependent effect) decreases LPL activity.
3
Diabetic dyslipidemia typically comprises moderately increased triglyceride, low high density lipoprotein cholesterol (HDLc), a predominance of small dense LDL particles (phenotype B), and increased apolipoprotein B (apoB), with low density lipoprotein cholesterol (LDLc) concentrations comparable to those of a background population.
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The management of diabetic dyslipidemia should aim for all the lipoprotein abnormalities identified and is based upon a stepwise type of treatment, starting with lifestyle modifications and improvement of glycemic control. Lipid-lowering drugs should be used when targets are not met with the previous measures.
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The management of Type 2 diabetes not only depends upon blood glucose control & blood pressure control, but life style management like obesity, exercise & also lipid profile management. Type 2 DM is becoming common in younger age group and the management is not depended upon blood glucose control only as mentioned and lipid profile abnormality is common in Type 2 diabetic patients. Prevalence of lipid profile abnormality may not uncommon in young Type 2 diabetics which is common in elderly Type 2 diabetic patients. Because younger age groups require longer s u r v i v a l c o m p a r e d to elderly patients to reach their target life. So for longer survival of y o u n g e r age Type 2 diabetic p a t i e n t s ; management of lipid p r o f i l e abnormality d e f i n i t e l y takes an i m p o r t a n t role. Blood sample was collected from the ante cubical vein with proper asepsis. Fluoride containing vials were used for collection of sample for plasma glucose estimation and for Lipid profile plain vials were used. Sample transferred to the Department of Biochemistry with in 2 hours maintaining cold chain. Subjects were selected after filling up the questionnaire. The study subjects also were asked to get prepare themselves as per advice, before the blood samples were drawn. At the initial steps, the Serum was separated by centrifugation and then subsequent investigation procedure was followed. A. Estimation of Fasting Blood Sugar: Principle: Glucose is oxidized to gluconic acid and hydrogen peroxide in the presence of glucose oxidases. Hydrogen peroxide further reacts with phenol and 4-aminoantipyrine by the catalytic action of peroxidase to form a red colored 'quinoneimine dye complex'. Intensity of the color formed is directly proportional to the amount of glucose present in the sample. could not be excluded totally due to lack of proper investigating tools. 2. Thorough diet survey could not be done due to time constraint. Pearson Chi-Square= 59.342, df= 10, p.value = 0.00 Table 2 Shows that 4 % of less than 25 years age group have high total cholesterol level & 80 % of study population of above 60 years of age group have high total cholesterol level. The prevalence of total cholesterol significantly increases with increase in age (p<0.05). Pearson Chi-Square= 17.689, df= 2, p.value = 0.000 Table 4 Shows that Total cholesterol is increasing in higher income group (54.1%) than low income group (7.7%). The result is highly significant (<0.05). Pearson Chi-Square= 66.484 df=2.,p.value =0.000 Table 5 Shows that 12 % of less than 25 years age group have high HDL and only 6% of more than 60 years age group have high HDL. The comparison is highly significant (<0.05). 21 A significant component of the risk associated with type 2 diabetes is thought to be because of its characteristic lipid "triad" profile of raised small dense low-density lipoprotein levels, lowered highdensity lipoprotein, and elevated triglycerides (TGs). 22 Longitudinal epidemiology has pointed to the importance of raised plasma triglycerides and low HDL Cholesterol as a risk factor for coronary disease in diabetic subjects and there is supportive evidence for aggressive management of lipid disorders in type 2 diabetes.
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Conclusion:
In the present study majority of patients of older age group have high LDL and low HDL in comparison to younger age group. 74% of less than 25 years age group have high triglyceride level & 86% of more than 60 years age group have high triglyceride level high. Total cholesterol is increasing in higher income and urban area group than low income group and rural area. Diabetes mellitus increases the risk for atherosclerotic vascular disease. The risk is greatest in people who have other known risk factors, such as, dyslipidaemia, hypertension, smoking and obesity. There is a twofold to fourfold excess risk of coronary artery disease in type 2 diabetes mellitus compared with non-diabetic patients. Indeed, 75-80% of adult diabetic patients die of coronary artery disease, cerebrovascular disease, peripheral vascular disease or a combination of these conditions. Patients with type 2 diabetes can have many lipid abnormalities, including hyperchylomicronaemia, elevated levels of very low-density lipoprotein cholesterol (VLDL-C),low-density lipoprotein cholesterol (LDL-C) and triglycerides; and low levels of high-density lipoprotein cholesterol (HDL-C). Lipid abnormalities may be the result of the unbalanced metabolic state of diabetes (i.e., hyperglycaemia and insulin resistance) and improved control of hyperglycaemia does moderate diabetes-associated dyslipidaemia. In type 2 diabetes the major disturbances in lipoprotein metabolism are reflected by an increase in plasma triglyceride and a low HDL Cholesterol with normal or near normal LDL Cholesterol levels.
Aggressive therapy of diabetic dyslipidemia will probably reduce the risk of CHD in patients with diabetes. Primary therapy should be directed first at lowering LDL levels & improving HDL levels.
